TTM
$1.10B
YoY change
+19.3%
5Y CAGR
+12.7%
Peak year (2025)
$1.06B
Cumulative net income
$8.25B
Net Income history chart for IDEXX Laboratories (IDXX) from 1991 to 2025
Latest: $1.06B
Net Income growth chart for IDEXX Laboratories (IDXX) from 1991 to 2025
Latest: +19.3%
Net Income history table for IDEXX Laboratories (IDXX) from 1991 to 2025
| 2025 | $1.06B | +19.3% | +$171.60M | ||
| 2024 | $887.87M | +5.1% | +$42.83M | ||
| 2023 | $845.04M | +24.4% | +$165.95M | ||
| 2022 | $679.09M | -8.8% | −$65.76M | ||
| 2021 | $744.85M | +28.0% | +$163.07M | ||
| 2020 | $581.78M | +36.0% | +$154.06M | ||
| 2019 | $427.72M | +13.4% | +$50.69M | ||
| 2018 | $377.03M | +43.3% | +$113.89M | ||
| 2017 | $263.14M | +18.5% | +$41.10M | ||
| 2016 | $222.04M | +15.6% | +$29.97M | ||
| 2015 | $192.08M | +5.6% | +$10.17M | ||
| 2014 | $181.91M | -3.1% | −$5.89M | ||
| 2013 | $187.80M | +5.3% | +$9.53M | ||
| 2012 | $178.27M | +10.2% | +$16.48M | ||
| 2011 | $161.79M | +14.5% | +$20.50M | ||
| 2010 | $141.28M | +15.6% | +$19.06M | ||
| 2009 | $122.22M | +5.2% | +$6.06M | ||
| 2008 | $116.17M | +23.6% | +$22.16M | ||
| 2007 | $94.01M | +0.4% | +$336.00K | ||
| 2006 | $93.68M | +19.7% | +$15.42M | ||
| 2005 | $78.25M | -0.1% | −$78.00K | ||
| 2004 | $78.33M | +37.2% | +$21.24M | ||
| 2003 | $57.09M | +25.8% | +$11.70M | ||
| 2002 | $45.39M | +20.7% | +$7.77M | ||
| 2001 | $37.62M | +2.7% | +$988.00K | ||
| 2000 | $36.63M | +12.4% | +$4.03M | ||
| 1999 | $32.60M | -314.5% | +$47.80M | ||
| 1998 | −$15.20M | -28.0% | +$5.90M | ||
| 1997 | −$21.10M | -164.7% | −$53.70M | ||
| 1996 | $32.60M | +51.6% | +$11.10M | ||
| 1995 | $21.50M | +61.7% | +$8.20M | ||
| 1994 | $13.30M | +37.1% | +$3.60M | ||
| 1993 | $9.70M | +98.0% | +$4.80M | ||
| 1992 | $4.90M | +53.1% | +$1.70M | ||
| 1991 | $3.20M | — | — |
- 2025$1.06B+19.3%
- 2024$887.87M+5.1%
- 2023$845.04M+24.4%
- 2022$679.09M-8.8%
- 2021$744.85M+28.0%
- 2020$581.78M+36.0%
- 2019$427.72M+13.4%
- 2018$377.03M+43.3%
- 2017$263.14M+18.5%
- 2016$222.04M+15.6%
- 2015$192.08M+5.6%
- 2014$181.91M-3.1%
- 2013$187.80M+5.3%
- 2012$178.27M+10.2%
- 2011$161.79M+14.5%
- 2010$141.28M+15.6%
- 2009$122.22M+5.2%
- 2008$116.17M+23.6%
- 2007$94.01M+0.4%
- 2006$93.68M+19.7%
- 2005$78.25M-0.1%
- 2004$78.33M+37.2%
- 2003$57.09M+25.8%
- 2002$45.39M+20.7%
- 2001$37.62M+2.7%
- 2000$36.63M+12.4%
- 1999$32.60M-314.5%
- 1998−$15.20M-28.0%
- 1997−$21.10M-164.7%
- 1996$32.60M+51.6%
- 1995$21.50M+61.7%
- 1994$13.30M+37.1%
- 1993$9.70M+98.0%
- 1992$4.90M+53.1%
- 1991$3.20M—
Net Income values are taken from IDEXX Laboratories's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Net Income at IDEXX Laboratories (IDXX)
According to IDEXX Laboratories's latest reported financial statements, the company's current net income (TTM) is $1.10B. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
2025's annual net income for IDEXX Laboratories (IDXX) came in at $1.06B – grew 19.3% year-over-year.
Over 2020–2025 (5 years), IDEXX Laboratories net income expanded at a +12.7% compound annual rate, sustaining 3 straight years of year-over-year growth.
2025 marks the peak net income at $1.06B, with the historical low of −$21.10M recorded in 1997.
IDEXX Laboratories Net Income by Year
IDEXX Laboratories Net Income 2025: $1.06B
In 2025, IDEXX Laboratories reported net income of $1.06B, grew 19.3% from 2024. This figure represents the highest annual value in the available history.
IDEXX Laboratories Net Income 2024: $887.87M
IDEXX Laboratories net income in 2024 was $887.87M, grew 5.1% from 2023.
IDEXX Laboratories Net Income 2023: $845.04M
2023's net income for IDEXX Laboratories came in at $845.04M, grew 24.4% from 2022.
IDEXX Laboratories Net Income 2022: $679.09M
IDEXX Laboratories posted net income of $679.09M in 2022, declined 8.8% below 2021.
IDEXX Laboratories Net Income 2021: $744.85M
IDEXX Laboratories net income in 2021 was $744.85M.
See more financial history for IDEXX Laboratories (IDXX).
Sector peers by Net Income
Healthcare peers of IDEXX Laboratories (IDXX), ranked by their latest net income
| $26.80B | |
| $20.64B | |
| $18.25B | |
| $15.97B | |
| $12.06B | |
| $10.26B | |
| $7.71B | |
| $4.23B |
- $26.80B
- $20.64B
- $18.25B
- $15.97B
- $12.06B
- $10.26B
- $7.71B
- $4.23B
Frequently asked questions
IDEXX Laboratories (IDXX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation